Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
Clinical trial NCT04276883 · COMPLETED
Trial details
- NCT number
- NCT04276883
- Sponsor
- BioXcel Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-24
- Primary completion
- 2020-05-21
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.